Skip to main content

IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Now Playing

    Melanoma vaccine trial appears to reduce skin cancer recurrence

    03:19

  • UP NEXT

    More than 175 people contract norovirus on Celebrity cruise ship

    00:26

  • How make the most out of a rest day with active recovery

    03:27

  • Kick off summer with these health tips from the Start TODAY community

    23:51

  • Migraines 101: Know the signs, symptoms and treatments

    04:11

  • Moms on Mushrooms uses psychedelics to treat depression

    04:12

  • How to prepare for the chance of injury and illness on trips

    04:44

  • Start TODAY’s June 2023 walking challenge: What to know

    05:02

  • 5 reasons to join Start TODAY walking challenge

    05:04

  • Former NFL player tackles mental health in Black community

    04:29

  • Ticks, heat rash, hydration and more: How to enjoy summer safely

    04:42

  • Author and podcast host Case Kenny talks mindfulness journey

    04:18

  • Tips and techniques to build confidence

    04:35

  • Jillian Michaels talks injury, demonstrates 3 exercises for longevity

    04:43

  • Salmonella outbreak in 6 states linked to raw cookie dough

    00:29

  • Multivitamins may help slow age-related memory loss, study shows

    02:39

  • Sunblock, sunscreen, SPF: How to choose the right sun protection

    04:25

  • Twins turn tragedy into lifetime dedicated to neurologic research

    05:05

  • Dylan Dreyer opens up about son Calvin’s celiac disease diagnosis

    06:58

  • Did Ozempic tap into a potential addiction cure?

    05:43

Drug companies Moderna and Merck have released encouraging results from a vaccine trial that shows promise in the battle against Stage 3 and Stage 4 melanoma, the most serious type of skin cancer. NBC’s Dr. Natalie Azar breaks down the findings on TODAY.

Source

Leave a Reply